Status:
RECRUITING
Methotrexate Treatment in Cases of Ectopic Pregnancy With Relative Contraindications
Lead Sponsor:
Bagcilar Training and Research Hospital
Conditions:
Ectopic Pregnancy
Eligibility:
FEMALE
18-48 years
Brief Summary
Study Description (For Patients, Families, and Healthcare Providers) Purpose: The aim of this study is to evaluate the effectiveness and safety of methotrexate treatment in women with ectopic pregna...
Detailed Description
Background and Justification of the Study Ectopic pregnancy poses a significant risk in terms of maternal morbidity and mortality and accounts for approximately 1-2% of all pregnancies. With the advan...
Eligibility Criteria
Inclusion
- Diagnosed with ectopic pregnancy
- Received methotrexate (MTX) treatment
- Underwent surgical treatment due to lack of response to MTX therapy
- Compliant with treatment follow-up
Exclusion
- Participants with contraindications to methotrexate (MTX) treatment
- Participants non-compliant with follow-up
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT07186127
Start Date
May 1 2025
End Date
May 1 2026
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Health Sciences, Training and Research Hospital
Istanbul, Türkiye, Turkey (Türkiye), 34200